Earnings summaries and quarterly performance for Petco Health & Wellness Company.
Executive leadership at Petco Health & Wellness Company.
Joel Anderson
Detailed
Chief Executive Officer
CEO
Glenn Murphy
Detailed
Executive Chairman
Giovanni Insana
Chief Legal Officer and Secretary
Holly May
Chief Human Resources Officer
Jack Stout
Chief Merchandising Officer
Joe Venezia
Chief Revenue Officer
Michael Romanko
Chief Customer and Product Officer
Sabrina Simmons
Chief Financial Officer
Board of directors at Petco Health & Wellness Company.
Research analysts who have asked questions during Petco Health & Wellness Company earnings calls.
Kendall Toscano
Bank of America
12 questions for WOOF
Also covers: ACI, SFM
Oliver Wintermantel
Evercore ISI
10 questions for WOOF
Also covers: FND, W, WSM
Simeon Gutman
Morgan Stanley
10 questions for WOOF
Also covers: AAP, ACI, ARHS +32 more
Kaumil Gajrawala
Jefferies
9 questions for WOOF
Also covers: BARK, BRBR, BTMD +22 more
Steven Zaccone
Citigroup
9 questions for WOOF
Also covers: AAP, AZO, BBY +14 more
Peter Benedict
Robert W. Baird & Co.
8 questions for WOOF
Also covers: ARHS, BJ, COOK +9 more
Jacob Nivasch
Guggenheim Securities, LLC
6 questions for WOOF
Michael Lasser
UBS
6 questions for WOOF
Also covers: AAP, ASO, AZO +24 more
Sachin Verma
UBS Group AG
6 questions for WOOF
Also covers: SVV
Christopher Bottiglieri
BNP Paribas
3 questions for WOOF
Also covers: CPRT, CVNA, KMX +2 more
Steven Forbes
Guggenheim Securities, LLC
3 questions for WOOF
Also covers: AAP, ARHS, AZO +15 more
Kate McShane
Goldman Sachs
2 questions for WOOF
Also covers: ASO, AZO, BBWI +19 more
Seth Basham
Wedbush Securities
2 questions for WOOF
Also covers: AAP, ARHS, ASO +9 more
Steve Forbes
Guggenheim
2 questions for WOOF
Also covers: DKS, ETSY, POOL +2 more
Zach Fadem
Wells Fargo
2 questions for WOOF
Also covers: LOW, TSCO
David Lane
Wells Fargo
1 question for WOOF
David Lantz
Wells Fargo & Company
1 question for WOOF
Also covers: MCW, MNRO, VVV
Julio Marquez
Guggenheim Securities
1 question for WOOF
Also covers: ARHS, BYON
Justin Kleber
Robert W. Baird & Co.
1 question for WOOF
Also covers: ASO, AZO, DKS +6 more
Lauren Hang
Morgan Stanley
1 question for WOOF
Lauren Ng
Morgan Stanley
1 question for WOOF
Also covers: AZO, BBY, LESL +1 more
Matt McCartney
Wedbush Securities
1 question for WOOF
Steven Shemesh
RBC Capital Markets
1 question for WOOF
Also covers: OLLI, VVV
Zachary Fadem
Wells Fargo
1 question for WOOF
Also covers: AAP, AZO, CMG +11 more
Recent press releases and 8-K filings for WOOF.
Petco Reports Profitable Q3 2026, Raises 2025 Adjusted EBITDA Outlook, and Prepares for 2026 Growth
WOOF
Earnings
Guidance Update
New Projects/Investments
- Petco delivered a profitable Q3 2026, with operating income increasing over $25 million and adjusted EBITDA reaching $99 million. Gross margin expanded by approximately 75 basis points to 38.9%, and operating margin expanded over 170 basis points, despite net sales being down 3.1%.
- For 2025, Petco is raising its adjusted EBITDA outlook to between $395 million and $397 million, representing an approximate 18% year-over-year increase at the midpoint, while narrowing its net sales outlook to be down between 2.5% and 2.8%.
- The company is strategically shifting resources towards a return to growth in 2026, focusing on product differentiation, an enhanced store experience, integrated services, and a seamless omni-experience. A new membership program is being piloted in Q4 2025 for a 2026 rollout.
- Petco generated $61 million in free cash flow for Q3 2026 and expects to reduce its net debt to EBITDA ratio to below 3.5 times by the end of 2025.
Nov 25, 2025, 9:30 PM
Petco Reports Q3 2025 Results and Raises Full-Year Adjusted EBITDA Outlook
WOOF
Earnings
Guidance Update
New Projects/Investments
- Petco reported a profitable Q3 2025, achieving $99 million in adjusted EBITDA and $61 million in free cash flow, despite net sales decreasing by 3.1%.
- The company raised its full-year 2025 adjusted EBITDA outlook to between $395 million and $397 million, an 18% increase at the midpoint year-over-year, and narrowed its full-year net sales guidance to be down between 2.5% and 2.8%.
- Gross margin expanded by approximately 75 basis points to 38.9% in Q3 2025, driven by disciplined pricing, although tariffs began to meaningfully impact cost of goods sold and are expected to be more significant in Q4.
- Petco is shifting resources towards "phase three" for a return to growth in 2026, focusing on four pillars: product differentiation, an enhanced store experience, integrated services, and a seamless omni-channel approach, with a new membership program being piloted in Q4.
Nov 25, 2025, 9:30 PM
Petco Reports Q3 2026 Results and Raises Full-Year 2025 Adjusted EBITDA Outlook
WOOF
Earnings
Guidance Update
New Projects/Investments
- Petco delivered a profitable Q3 2026, reporting adjusted EBITDA of $99 million and free cash flow of $61 million. Net sales decreased 3.1%, and comparable sales were down 2.2%.
- The company achieved significant profitability improvements, with gross margin expanding approximately 75 basis points to 38.9% and adjusted EBITDA margin expanding nearly 140 basis points to 6.7% of sales.
- Petco raised its full-year 2025 adjusted EBITDA outlook to between $395 million and $397 million, representing an increase of roughly 18% year-over-year at the midpoint. Full-year net sales are now expected to be down between 2.5% and 2.8%.
- For Q4 2025, adjusted EBITDA is projected between $93 million and $95 million, with net sales expected to be down low single digits, reflecting a more meaningful impact from tariffs and planned selective investments.
- The company is transitioning to Phase III of its transformation, focusing on a return to growth in 2026, supported by four strategic pillars, and expects its net debt to EBITDA ratio to be below 3.5 times by year-end 2025, down from over 4 times at the start of the year.
Nov 25, 2025, 9:30 PM
Petco reports Q3 2025 results, raises 2025 Adjusted EBITDA outlook
WOOF
Earnings
Guidance Update
Revenue Acceleration/Inflection
- Petco reported a significant improvement in profitability for Q3 2025, with Operating Income increasing by ~$25 million and Adjusted EBITDA rising by ~$17 million.
- The company generated Free Cash Flow of ~$61 million in Q3 2025 and reduced Net Debt by 8% year-over-year to $1.36 billion.
- Petco raised its Full Year 2025 Adjusted EBITDA outlook to $395 million to $397 million, reflecting continued execution on profitability goals.
- While Q4 2025 Net sales are expected to be down low single digits year-over-year, the company anticipates sales growth in 2026 as it focuses on strengthening fundamentals and implementing a new economic model.
Nov 25, 2025, 9:30 PM
Petco Health and Wellness Company Reports Q2 2026 Results and Raises Full-Year 2025 Adjusted EBITDA Outlook
WOOF
Earnings
Guidance Update
New Projects/Investments
- Petco Health and Wellness Company reported Q2 2026 adjusted EBITDA of $114 million and generated over $50 million in free cash flow, while net sales were down 2.3% and comparable sales were down 1.4%.
- The company achieved gross margin expansion of more than 120 basis points to 39.3% and decreased SG&A by $36 million in Q2 2026, reflecting progress in strengthening its economic model.
- Petco raised its full-year 2025 adjusted EBITDA outlook to between $385 million and $395 million, an increase of roughly 16% at the midpoint, while maintaining net sales guidance to be down low single digits.
- The company is currently in Phase two of its transformation, focusing on improving profitability and retail fundamentals, and anticipates a return to positive comparable sales in 2026, with selective investments beginning in the second half of 2025 to prepare for Phase three growth.
- Tariff impacts are expected to become sequentially more meaningful in the second half of 2025, particularly in Q4.
Aug 29, 2025, 8:21 AM
Petco Health & Wellness Company Reports Q2 2025 Results and Updates 2025 Outlook
WOOF
Earnings
Guidance Update
Demand Weakening
- Petco Health & Wellness Company meaningfully increased profitability in Q2 2025, with operating income increasing by approximately $41 million and Adjusted EBITDA increasing by approximately $30 million.
- Despite profitability gains, net sales declined by 2% and 1-year comparable sales were down 1% in Q2 2025.
- The company generated Free Cash Flow of approximately $54 million in Q2 2025 and reduced Net Debt by 4% year-over-year to $1.40 billion as of Q2 2025.
- Petco raised its full-year 2025 Adjusted EBITDA outlook to a range of $385 million to $395 million, up from the prior outlook of $375 million to $390 million.
Aug 28, 2025, 8:30 PM
Class Action Lawsuit Filed Against Petco Health and Wellness Company, Inc.
WOOF
Legal Proceedings
Guidance Update
Management Change
- A class action lawsuit has been filed against Petco Health and Wellness Company, Inc. (WOOF) and certain officers, alleging violations of federal securities laws during the Class Period from January 14, 2021, to June 5, 2025.
- The complaint alleges that Petco made materially false and misleading statements, overstating its business model's sustainability and ability to deliver profitable growth, particularly concerning its premium pet food strategy.
- Petco repeatedly negatively revised its FY 2023 guidance for adjusted EBITDA and EPS; adjusted EBITDA guidance fell from an initial range of $520 million to $540 million to approximately $400 million, and adjusted EPS guidance from $0.40 to $0.48 to approximately $0.08.
- The company experienced significant stock price declines following these negative revisions and other disclosures, including a 20.64% drop on August 24, 2023, a 28.91% drop on November 29, 2023, and a 23.2% drop on June 6, 2025, after reporting a 1.3% decline in Q1 FY 2025 comparable sales.
- Several key executives, including the CEO, CFO, Chief Customer Officer, Chief Operating Officer, and Chief Merchandising and Supply Chain Officers, have stepped down or been terminated since March 2024.
Jul 10, 2025, 1:00 PM
Petco Health and Wellness Company, Inc. Faces Class Action Lawsuit
WOOF
Legal Proceedings
Guidance Update
Management Change
- Pomerantz LLP has filed a class action lawsuit against Petco Health and Wellness Company, Inc. and certain officers, covering the period between January 14, 2021, and June 5, 2025.
- The lawsuit alleges that Petco made materially false and misleading statements, including that its pandemic-related tailwinds and premium product business model were unsustainable, and that the company overstated its ability to deliver sustainable, profitable growth.
- Petco negatively revised its fiscal full year (FY) 2023 adjusted EBITDA guidance from an initial $520 million to $540 million to $460 million to $480 million in August 2023, and further to approximately $400 million in November 2023.
- The company's stock price experienced significant declines following these disclosures, including a 20.64% drop on August 24, 2023, and a 28.91% drop on November 29, 2023.
- Several key executives, including the CEO, Chief Customer Officer, Chief Operating Officer, Chief Merchandising and Supply Chain Officers, and CFO, departed between March 2024 and February 2025.
Jul 6, 2025, 2:00 PM
Petco Health Q4 2025 Results Highlight Operational Improvements
WOOF
Earnings
Guidance Update
Revenue Acceleration/Inflection
- Q4 2025 Performance: Reported net sales of $1.55 billion with adjusted EBITDA of $96.1 million and a gross margin improvement to 38%, reflecting robust operational adjustments.
- Operational Efficiency Initiatives: Focus on restoring retail fundamentals through pricing adjustments, cost controls, and strategic store closures (25 net closures in 2024 with an additional 20-30 expected in 2025) to eliminate underperforming locations.
- Strategic Guidance for 2025: On track for a low single-digit decline in net sales with full-year adjusted EBITDA projected between $375 million and $390 million, and Q1 adjusted EBITDA expected to increase about 9% year-over-year.
- Phased Growth Strategy: Implementation of a multi-phase plan—first strengthening the operating model and retail fundamentals, followed by testing revenue growth levers—to position the company for sustainable, long-term profitability.
Mar 26, 2025, 8:31 PM
Petco Health Reports Solid Q4 2025 Results and Provides FY 2025 Guidance
WOOF
Earnings
Guidance Update
- Q4 2025 performance was marked by strengthened retail fundamentals with comparable store sales improving by 0.5% and adjusted EBITDA of $96.1M exceeding prior outlook.
- The company achieved positive free cash flow of $49.7M in FY24 and provided FY 2025 guidance with net revenue expected to decline in low single digits and adjusted EBITDA forecast between $375M and $390M.
Mar 26, 2025, 8:30 PM
Quarterly earnings call transcripts for Petco Health & Wellness Company.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more